Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company VentiRx Pharmaceuticals Inc.
DescriptionSmall molecule TLR8 agonist
Molecular Target Toll-like receptor 8 (TLR8)
Mechanism of ActionToll-like receptor 8 (TLR8) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationRhinitis
Indication DetailsTreat allergic rhinitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today